With its ability to mimic the action of the GLP-1 and GIP hormones, tirzepatide can play a crucial role in supporting weight management efforts and achieving healthier outcomes for those with Type 2 diabetes or obesity
The Drug Controller General of India (DCGI) had earlier provided its approval for manufacturing and marketing Semaglutide injection for the treatment of both Type 2 Diabetes Mellitus and Obesity indications
These multi-agonist therapies, like tirzepatide, have shown superior clinical outcomes compared to monotherapies, attracting strong interest from both clinicians and patients
Manage Stress High cortisol counteracts GH
Lifestyle Factors and Metabolic Health Optimization Tirzepatide works most effectively when combined with consistent physical activity (150+ min/week moderate intensity), adequate protein intake (0.81.2 g/kg body weight), and sleep optimization
That said, microdosing GLP-1s is considered off-label use